Headlines:
Search for Healthcare Articles by Regulatory & Product Marketing

Blockbuster Management


< Previous   Page 2 of 4   Next >
Search returned 32 items.
sort by:   Title | Author | Publication | Date

Forecast 2007: At Sea

The new year started early for pharma—and with a bang. Hard on the Democratic win in the midterm elections came the industry leader's week from hell
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395602

Sales Slip

Even before Pfizer blinked, companies were asking, What ails sales? In this annual survey,
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395596

Eisai award recognizes R.Ph.s' role in Alzheimer's care

For five years now, Eisai, maker of Aricept (donepezil HCl), has offered an annual recognition award
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=385549

What Type of Brand Are You?

Stop the aimless soul searching. The path to brand success lies in understanding how best to position your drug.
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=333312

2005 Rx Market: The highs and lows

Lack of blockbuster launches makes for uneventful year; still, scripts rise 3%...
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=312505

Cigna hopes to involve R.Ph.s in diabetes project

A program using claims and refills data to identify diabetes patients...
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=302233

Introduction: Opportunites and Challenges

Blockbuster drugs that represent 50 to 60 percent of pharmaceutical sales will come off patent in the next few years...
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=285291

SECOND OPINION: Generalist physicians т€Â&8220; added value in a crisis

This month, I'm sharing this space with a colleague on the Patient Care Board of Editors...
http://www.patientcareonline.com/patcare/article/articleDetail.jsp?id=197805

Generic Pharma Battles for Allegra Rights

Rival generic drug makers have struck a deal to create a competitive edge in what has become an overly...
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=2754

Building Blockbusters

The most lucrative new drugs are often less glamorous than first-in-class NMEs. And they are much less risky.
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=177965
< Previous   Page 2 of 4   Next >
Search returned 32 items.
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
Place your ad in this
Must-Read Pharma Mag
www.biotechmedia.com
Over 8,000,000 Mail and
Email addresses available
www.biotechmedia.com